Events picture

A. Thomas McLellan, PhD December 14, 2012, 12:00 pm - 1:30 pm WPIC Auditorium

Department of Psychiatry Lecture Series
Distinguished Scientist Lecture

Healthcare Reform:  How Will It Affect Care for Substance Use Disorders?

A. Thomas McLellan, PhD
President & CEO
Treatment Research Institute

Dr. McLellan is the Chief Executive Officer and co-founder of the Treatment Research Institute (TRI) in Philadelphia, PA, an independent non-profit dedicated to science-driven transformation of treatment, other practice and policy in substance use and abuse.  He is also an experienced substance abuse researcher, and previously served as Deputy Director of the White House Office of National Drug Control Policy (ONDCP), a Congressionally confirmed Presidential appointment to help shape the nation’s public policy approach to illicit drug use.  At ONDCP, Dr. McLellan worked on a broad range of issues, including formulation and implementation of the President’s National Drug Control Strategy and promotion of drug treatment through the broader revamping of the national health care system.  He has over 35 years of experience in addiction treatment research. As the co-founder of TRI, Dr. McLellan’s set out to transform the way research is employed in the treatment of and policy making around substance use and abuse.   He has published over 400 articles and chapters on addiction research, served from 2000-2009 as the Editor-in-Chief of the Journal of Substance Abuse Treatment, and has also served on several other editorial boards of scientific journals.  Among his many awards and honors are Life Achievement Awards from the American and British Societies of Addiction Medicine, the Robert Wood Johnson Foundation Innovator Award, and awards for Distinguished Contribution to Addiction Medicine from the Swedish and Italian Medical Associations.

Learning Objectives: After attending this session, learners will be able to:

  1. Understand previously unavailable insurance benefits that should now be available to individuals with substance use disorders thanks to the Affordable Care Act.
  2. Identify three significant problems in general healthcare quality that may be improved through more accessible substance abuse treatment in general health settings.
  3. Describe the relationships between the Affordable Care Act and the Mental Health and Substance Abuse Parity Act.

Continuing Education Credit: The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits TM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded .15 continuing education units (CEUs), which are equal to 1.5 contact hours. In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, information about relationships of presenters with commercial interests (if any) will be included in materials which will be distributed at the time of the conference.  WPIC is approved by the American Psychological Association to offer continuing education for psychologists.  WPIC maintains responsibility for this program and its contents.  This program is being offered for 1.5 continuing education credits.

For more information, please contact Jeanie Knox Houtsinger at knoxjv@upmc.edu.